Archana Asundi, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Infectious Diseases

MD, McGill University
BA, Tufts University

Pronouns: she/her/hers

Dr. Archana Asundi is a physician-scientist and infectious disease clinician, who specializes in care of people living with HIV with a specific focus on HIV and Aging. In her role Director of the Infectious Disease Clinical Research Unit (ID-CRU) at Boston Medical Center, she supports and oversees the conduct of a large portfolio of clinical trials and clinical-translational research studies in the Center for Infectious Disease (CID). Her individual research program focuses on investigating cardiometabolic comorbidities and weight gain/obesity among people living with HIV. She also engages in quality improvement and continuing medical education in the area of HIV and aging with several projects ongoing targeted around improvement of health-related quality of life among people aging with HIV.

GS-US-563-6041: A Phase 2 Randomized, Open-Label, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of Islatravir in Combination with Lenacapavir in Virologically Suppressed People with HIV
04/06/2023 - 12/31/2027 (PI)
Gilead Sciences

10/27/2022 - 10/27/2025 (PI)

Gamma delta T cells promote inflammation in aviremic HIV infection and normal aging
08/15/2020 - 05/31/2025 (PI)
Trustees of Boston University, BUMC National Institute o

Launching a geriatrics and HIV-ID integrated clinic to improve care for people aging with HIV: The HIVE program
08/01/2022 - 07/31/2024 (PI)
Health Resources and Services Administration/DHHS

Solar GSK213500: A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine administer
01/25/2021 - 01/24/2024 (PI)

Is Integrase Inhibitor Emergent Weight Gain associated with increased Cardiometabolic Risk? A Nationwide Cohort Analysis
01/24/2022 - 01/23/2024 (PI)
Gilead Sciences

Real-world Clinical Insights and Inflammatory Mechanisms of Integrase Strand Transfer Inhibitor Associated Excessive Weight Gain
07/01/2021 - 12/30/2023 (PI)
The Miriam Hospital National Institute o


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Pihl RMF, Smith-Mahoney EL, Olson A, Yuen RR, Asundi A, Lin N, Belkina AC, Snyder-Cappione JE. Distinct subsets of Vd1 effector and Vd2 ?d T cells shift in frequency and are linked to plasma inflammatory markers during ART-suppressed HIV infection. J Infect Dis. 2024 Feb 23.View Related Profiles. PMID: 38390982
  2. Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A. Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting. medRxiv. 2023 Jun 03. PMID: 37398278; PMCID: PMC10312897; DOI: 10.1101/2023.05.26.23290576;
  3. Asundi A, Olson A, Jiang W, Varshney SP, White LF, Sagar M, Lin NH. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus. AIDS Res Hum Retroviruses. 2022 03; 38(3):208-215.View Related Profiles. PMID: 34877881; PMCID: PMC8968841; DOI: 10.1089/aid.2021.0091;
  4. Asundi A, O'Leary C, Bhadelia N. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges. Cell Host Microbe. 2021 07 14; 29(7):1036-1039.View Related Profiles. PMID: 34265241; PMCID: PMC8279498; DOI: 10.1016/j.chom.2021.06.007;
  5. Asundi A, Resnik J, Benedict PA, Shin M, Rani Elwy A, Branch-Elliman W. How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols. Open Forum Infect Dis. 2021 Apr; 8(4):ofab072.View Related Profiles. PMID: 33855102; PMCID: PMC8026152; DOI: 10.1093/ofid/ofab072;
  6. Asundi A, Stanislawski M, Mehta P, Mull HJ, Schweizer ML, Barón AE, Ho PM, Gupta K, Branch-Elliman W. Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program. Sci Rep. 2020 03 24; 10(1):5276.View Related Profiles. PMID: 32210289; PMCID: PMC7093485; DOI: 10.1038/s41598-020-62083-y;
  7. Mull HJ, Stolzmann K, Kalver E, Shin MH, Schweizer ML, Asundi A, Mehta P, Stanislawski M, Branch-Elliman W. Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record. BMC Med Inform Decis Mak. 2020 01 30; 20(1):15.View Related Profiles. PMID: 32000780; PMCID: PMC6993312; DOI: 10.1186/s12911-020-1031-5;
  8. Asundi A, Bhadelia N. Making Emergency Use of Experimental Vaccines Safer. AMA J Ethics. 2020 01 01; 22(1):E43-49.View Related Profiles. PMID: 31958390
  9. Asundi A, Cervantes-Arslanian AM, Lin NH, Barbosa F. Infectious Myelitis. Semin Neurol. 2019 08; 39(4):472-481.View Related Profiles. PMID: 31533188
  10. Asundi A, Robles Y, Starr T, Landay A, Kinslow J, Ladner J, White L, Plank RM, Melbourne K, Weisholtz D, Bennett M, Pan H, Stern E, Lin A, Kuritzkes DR, Lin NH. Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593.View Related Profiles. PMID: 31045650; PMCID: PMC6625862; DOI: 10.1097/QAI.0000000000002079;
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 8 distinct years, with a maximum of 4 publications in 2019

Contact for Mentoring:
Asundi's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department